BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31318579)

  • 21. Targeted and systematic cognitive freehand-guided transperineal biopsy: is there still a role for systematic biopsy?
    Neale A; Stroman L; Kum F; Jabarkhyl D; Di Benedetto A; Mehan N; Rusere J; Chandra A; Challacombe B; Cathcart P; Dasgupta P; Elhage O; Popert R
    BJU Int; 2020 Aug; 126(2):280-285. PubMed ID: 32320126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies.
    Hoge C; Maynor S; Guan T; Naffouje R; Rao M; Verma S; Sidana A
    J Endourol; 2020 Oct; 34(10):1095-1098. PubMed ID: 32631097
    [No Abstract]   [Full Text] [Related]  

  • 24. Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia.
    Jacewicz M; Günzel K; Rud E; Lauritzen PM; Galtung KF; Hinz S; Magheli A; Baco E
    Urol Oncol; 2021 Jul; 39(7):432.e1-432.e7. PubMed ID: 33257219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
    Briggs LG; Kim M; Gusev A; Rumpf F; Feldman A; McGovern F; Tabatabaei S; Dahl DM
    Urology; 2021 Sep; 155():26-32. PubMed ID: 34048827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.
    Nafie S; Pal RP; Dormer JP; Khan MA
    World J Urol; 2014 Aug; 32(4):971-5. PubMed ID: 24337167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
    Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
    Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy.
    Castellucci R; Linares Quevedo AI; Sánchez Gómez FJ; Cogollos Acuña I; Salmerón Béliz I; Muñoz Fernández de Legaría M; Salinas S; Martínez Piñeiro L
    Urologia; 2021 Feb; 88(1):69-76. PubMed ID: 33054607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy.
    Sivaraman A; Sanchez-Salas R; Ahmed HU; Barret E; Cathala N; Mombet A; Uriburu Pizarro F; Carneiro A; Doizi S; Galiano M; Rozet F; Prapotnich D; Cathelineau X
    Urol Oncol; 2015 Jul; 33(7):329.e7-11. PubMed ID: 25957713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience.
    Salagierski M; Kania P; Wierzchołowski W; Poźniak-Balicka R
    Cent European J Urol; 2019; 72(1):15-18. PubMed ID: 31011434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection.
    Wu CL; Kim M; Wu S; Lin SX; Crotty RK; Harisinghani M; Feldman AS; Dahl DM
    Hum Pathol; 2021 Nov; 117():101-107. PubMed ID: 34461132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
    Gershman B; Zietman AL; Feldman AS; McDougal WS
    Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?
    Abd-Alazeez M; Ahmed HU; Arya M; Allen C; Dikaios N; Freeman A; Emberton M; Kirkham A
    Urol Oncol; 2014 Aug; 32(6):741-7. PubMed ID: 24981993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.
    Hansen NL; Barrett T; Lloyd T; Warren A; Samel C; Bratt O; Kastner C
    BJU Int; 2020 Feb; 125(2):260-269. PubMed ID: 31306539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comparison of Prostate Cancer Detection between Visual Estimation (Cognitive Registration) and Image Fusion (Software Registration) Targeted Transperineal Prostate Biopsy.
    Khoo CC; Eldred-Evans D; Peters M; van Son M; van Rossum PSN; Connor MJ; Hosking-Jervis F; Tanaka MB; Reddy D; Bass E; Powell L; Ahmad S; Pegers E; Joshi S; Sri D; Wong K; Tam H; Hrouda D; Qazi H; Gordon S; McCracken S; Winkler M; Ahmed HU
    J Urol; 2021 Apr; 205(4):1075-1081. PubMed ID: 33207137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.